SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026158
Filing Date
2018-05-08
Accepted
2018-05-08 16:31:22
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv491726_10q.htm 10-Q 569690
2 EXHIBIT 31.1 tv491726_ex31-1.htm EX-31.1 11648
3 EXHIBIT 31.2 tv491726_ex31-2.htm EX-31.2 11306
4 EXHIBIT 32.1 tv491726_ex32-1.htm EX-32.1 5683
  Complete submission text file 0001144204-18-026158.txt   4278248

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20180331.xml EX-101.INS 907034
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20180331.xsd EX-101.SCH 41140
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20180331_cal.xml EX-101.CAL 45591
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20180331_def.xml EX-101.DEF 291294
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20180331_lab.xml EX-101.LAB 318101
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20180331_pre.xml EX-101.PRE 321135
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 18815107
SIC: 2834 Pharmaceutical Preparations